The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups - Prescott, R; Nakai, H; Saenko, EL (Blood, 1997)
et al.